What Is Chelohart? A Science-Based Guide to the Heart Peptide Bioregul

By Vlad, QI Supplements | Published July 2026

The heart beats around 100,000 times a day. It never stops. From the moment you were born to the moment you die, it keeps going.

After 50, that work starts to take a toll. Heart muscle cells lose efficiency. Protein synthesis slows. The heart adapts. It pushes harder to get the same output. But that pattern has limits.

Chelohart is the A-14 heart peptide bioregulator. Professor Vladimir Khavinson and his team at the St. Petersburg Institute of Bioregulation and Gerontology developed it. Like all Khavinson bioregulators, it targets one particular organ: the heart. It works at the cellular level. It signals cardiac cells to resume the protein synthesis that slows with age.

This guide covers what Chelohart is, how it works, what research shows, and how to use it with Ventfort and Cardio 3 for optimal results.

Looking for the product?
→ Chelohart 20 capsules — 10-day course
→ Chelohart 60 capsules — 30-day course
→ Cardio 3— Chelohart, Ventfort, and Vladonix in one capsule

What Is Chelohart

Chelohart is a natural peptide complex. It is extracted from cardiac tissue — specifically the cardiac muscle of young animals, typically calves under 10 months. It belongs to the Cytomax family of Khavinson bioregulators — the natural peptide complexes, as opposed to the faster synthetic Cytogens like Vesugen.

The peptide complex A-14 contains several short chain peptides. All of them target the same tissue: heart muscle. The main cells in heart muscle are myocardial cells, also called cardiomyocytes. These are the cells that contract and relax to pump blood. They do this about 100,000 times a day.

These cells do not replace themselves the way skin or gut cells do. They are with you for life. When they slow down, the heart works harder to cover the gap. Chelohart supports healthy protein synthesis in these cardiac cells before that pattern sets in.

What chelohart distinguishes from other heart supplements is its tissue specificity. It does not support the cardiovascular system broadly. It targets the heart muscle itself, at the cellular level, through multiple pathways that regulate gene expression and cellular function.

Chelohart is marketed primarily within the Russian Khavinson peptide bioregulator tradition. This is a scientific framework developed at the St. Petersburg Institute of Bioregulation and Gerontology over more than four decades. Peptide bioregulators are short amino acid chains of 2-7 residues. That small size is what allows them to enter cells and interact with DNA directly. Binding of peptides to DNA activates RNA polymerase, which then drives the protein synthesis the cell needs to function well.

Peptides should be free from foreign DNA or protein substances to ensure purity and bioactivity. The Khavinson extraction process uses a patented filtering method that removes foreign DNA and protein material, leaving only the active peptide complex. Chelohart is manufactured under USA GMP standards for safety. USA GMP manufacturing standards ensure consistent production quality from batch to batch.

How it differs from Cardiogen

You may have seen Cardiogen listed alongside Chelohart. They both target cardiac tissue, but they work differently.

Chelohart is a natural Cytomax. It is a complex extracted from animal tissues. It contains many short chain peptides. Cardiogen is a synthetic Cytogen. It is one specific peptide chain. The synthetic version acts faster. The natural complex acts more slowly and covers more of the heart tissue signaling range.

Most people start with Chelohart for general heart support. This mirrors the Vesugen and Ventfort pattern — synthetic for speed, natural for depth and duration.

How the Heart Ages

To understand what Chelohart does, you need to understand what happens to the heart as you get older. Most people know heart disease risk rises with age. Fewer people understand why the heart muscle itself becomes less efficient at the cellular level — separate from any disease process.

Here is what happens.

Myocardial cells run on protein. The proteins inside these cardiac cells handle contraction, energy production, waste removal, and signals. Every protein has a lifespan. Old proteins break down into amino acids and short peptides. Those peptides are supposed to tell the cell to build new proteins. That is the peptide-protein cycle Khavinson spent 40 years studying.

After 50, that cycle slows. Cellular metabolism becomes less efficient. The signals that drive protein synthesis become less frequent. Cardiac cell metabolism drops off. Each beat takes more energy. The heart adapts by working harder. Over years, that pattern affects cardiovascular function, recovery from effort, and overall heart resilience.

This age related cardiac decline is not disease. It is normal biological aging of heart tissue. The question Khavinson's research asked: can you slow that decline by restoring the signal environment in cardiac cells?

Chelohart is the answer his team built for heart muscle specifically.

How Chelohart Works at the Cellular Level

Chelohart works through multiple pathways. Understanding those pathways helps explain why a short course produces effects that last for months.

Gene expression and protein synthesis

The core mechanism is gene expression. Short chain peptides in the Khavinson system interact with specific regions of DNA in a tissue-selective way. They do not change genes. They influence which genes are active at a given time.

In heart muscle, the genes that produce proteins for contraction, energy production, and repair begin to express less well with biological aging. Chelohart provides the specific peptide sequences that prompt cardiac cells to restore more youthful gene expression patterns. When that happens, protein synthesis resumes. The cell starts rebuilding the proteins it needs to function well.

Mitochondrial function and energy production

Heart muscle cells have more mitochondria than almost any other cell type in the body. The heart needs constant energy. As cellular aging progresses, mitochondrial function declines. Energy production becomes less efficient. Fatty acid oxidation — the primary fuel source for cardiac cells — slows down.

Chelohart supports cellular metabolism in cardiac tissue, which includes the metabolic processes that feed mitochondrial function. Better mitochondrial function means more consistent energy production for each heartbeat. This is one of the reasons people who run Chelohart in a broader peptide regimen often notice improved cardiovascular performance over time.

Cellular repair and tissue regeneration

Cardiomyocyte metabolism also governs how well the heart tissue clears damaged proteins and rebuilds structural components. Cellular repair in heart tissue slows with age. Chelohart supports the cellular activity that drives this repair process. It promotes tissue regeneration at the cardiac level by restoring the signaling environment that tells cells to maintain their structure.

This is not tissue regeneration in the sense of growing new heart cells. It is the restoration of normal cellular repair activity that keeps existing cardiac cells functioning at a higher level for longer.

Synergistic effects with the cardiovascular system

The heart does not work alone. Circulatory efficiency depends on both heart function and vessel health. Chelohart addresses the cardiac muscle side. Ventfort addresses the vessel side. The synergistic effects of running both together is why Khavinson's protocols almost always combine them. Each one supports a different part of the cardiovascular system through multiple aspects of cellular activity.

The Research Behind Chelohart

The research on Khavinson bioregulators spans more than 40 years and over 775 published studies. Much of it covers the broad effects of the bioregulator program. That is the nature of the Khavinson system. These peptides work as part of a protocol, not as standalone drugs.

The 266-patient longevity trial

The most significant long-term clinical study in the Khavinson body of work followed 266 older patients over 6 to 8 years. Researchers at the St. Petersburg Institute of Bioregulation and Gerontology and the Institute of Gerontology in Kiev assessed the effects of peptide bioregulators on basic functions in aging adults. The clinical trials tracked cardiovascular health, immune system markers, endocrine function, and mortality rates.

The results showed that the bioregulators normalized heart function markers. They also improved scores in endocrine, immune, and nervous system indices. The study reported much lower mortality in the treatment group compared to controls on standard care [Khavinson VK, Morozov VG. Neuro Endocrinol Lett. 2003;24(3-4):233-240. PMID 14523363].

Heart health was one of the primary systems tracked. The patients were older adults already experiencing age related declines. The peptide protocol — which targeted cardiac tissue and vessel tissue — showed real improvements across cardiovascular function markers.

Animal models and animal studies

Beyond clinical studies in humans, the Khavinson body of work includes extensive animal studies. These animal models used young animals and aging animals to track how specific peptides affect cardiac cell metabolism, gene expression, and tissue structure over time. The animal studies confirmed that short chain peptides targeting cardiac tissue reduce age related decline in heart function at the cellular level.

This research base — spanning both animal studies and human clinical trials — gives Chelohart one of the most documented track records of any heart peptide bioregulator available today.

Peptide epigenetics

The 2015 Biochemistry Moscow paper on peptide epigenetics laid out the mechanism behind why bioregulators work through gene expression [DOI: 10.1134/S0006297915030062]. For cardiac cells, this means the cells can resume making the proteins they need to contract well, manage oxidative stress, and maintain the cellular function that keeps the heart muscle healthy over time.

The broader theory of tissue specific peptides is also covered in Khavinson's review "Peptides and Ageing" [PMID 12374906].

Chelohart vs Conventional Treatments

It is worth being direct about where Chelohart fits relative to conventional treatments for heart health.

Conventional treatments for diagnosed heart conditions — medications, procedures, symptom management — address pathology. They treat disease. Chelohart is a dietary supplement. It supports healthy cellular function in cardiac tissue as part of a wellness and aging support protocol.

The root cause of age related cardiac decline is the slowdown of cellular repair, protein synthesis, and cardiomyocyte metabolism at the cellular level. Chelohart addresses that root cause in the context of a dietary supplement, not as a medical treatment. It is not a replacement for conventional treatments prescribed by a healthcare professional for diagnosed conditions.

What chelohart distinguishes is its targeted approach: specific peptides for a particular organ, working at the cellular level rather than through symptom management.

For people with chronic conditions including heart failure or other diagnosed cardiac conditions, talk to your healthcare provider before starting any peptide regimen. Chelohart may have potential benefits as part of a broader wellness approach, but your healthcare professional's guidance takes priority, especially if you take other medications.

Chelohart vs Ventfort: Two Different Jobs

People often ask whether Chelohart and Ventfort are the same thing. They are not. They target different tissue and do different things.

Ventfort (A-3) targets blood vessel tissue. It supports vessel tone, flexibility, and wall repair. When you think about cardiovascular health in terms of blood flow and circulatory efficiency, Ventfort handles the plumbing side of the system.

Chelohart (A-14) targets cardiac tissue — the myocardial cells that make the heart beat. It supports healthy protein synthesis in those cells, helps maintain cardiac function, and addresses the cellular repair and cellular activity that keeps heart muscle working well. When you think about the heart as a muscle and its cardiovascular performance over time, Chelohart handles that directly.

This is why Khavinson's heart protocols combine both. The Cardiovascular System Peptide Bundle combines Ventfort, Chelohart, and Vladonix. Each targets a different part of the cardiovascular system. Together they address heart tissue, vessel tissue, and the immune system balance that affects both.

For more on Ventfort and vessel peptides, see Vesugen vs Ventfort: Which Vascular Peptide Is Right For You?

What Chelohart Is Designed to Support

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. The following describes the tissue-level mechanisms Chelohart was designed to support as a dietary supplement.

Chelohart is a dietary supplement with natural cardiac muscle peptides. It is designed to support:

Healthy protein synthesis in cardiac cells and heart tissue
Normal cardiac cell metabolism and cellular function as part of healthy aging
Mitochondrial function and energy production in heart muscle
Cellular repair and cellular regeneration in cardiac tissue
Overall vitality and cardiovascular health as part of a complete peptide protocol

It is not a treatment for heart failure or any other medical condition. It does not replace medication prescribed by a healthcare professional. It is a dietary supplement built on Khavinson's research into how specific peptides support particular organ tissues by restoring the cellular activity that maintains healthy function over time.

How to Take Chelohart: The Peptide Regimen

Standard protocol

Take 1 to 2 capsules, 1 to 2 times daily with meals. The standard course is 10 days for the 20-capsule pack or 30 days for the 60-capsule pack. This is an oral dietary supplement. There is no subcutaneous injection required. Unlike research peptides sold by some peptide suppliers for research purposes, Chelohart is an oral capsule designed for daily use.

The 10-day course is where most people start. The 30-day course suits people building a full heart protocol with Ventfort alongside it for optimal results.

After the course, take a break. Khavinson bioregulators have an after-effect. The cardiac cells keep making proteins for months after you stop. Most people repeat the course 2 to 4 times per year.

Storage

Store in a dry, dark place between 2°C and 25°C. Shelf life is 3 years from the production date. No sterile technique is required. These are oral capsules, not injectables.

Safety profile and contraindications

Bioregulators like Chelohart are considered non-toxic and non-allergenic in the Khavinson research literature. In published clinical studies, Chelohart has no reported serious side effects and no drug dependence. The scientific basis for this is structural: peptide bioregulators are short amino acid chains of 2-7 residues. They are too small to trigger immune responses in the way larger proteins do. They are recognized by the body as natural signaling molecules, not foreign substances.

Do not take if you have a known intolerance to any ingredient. Do not take during pregnancy or while breastfeeding. Consult your healthcare provider before starting if you take other medications, especially prescription heart medication. There are no known adverse interactions between Chelohart and other Khavinson peptide bioregulators, but always disclose all supplements to your healthcare professional.

Quality and sourcing

Chelohart is manufactured under USA GMP standards for safety. USA GMP manufacturing standards ensure consistent production quality and verify that each batch meets the same specification. If you are comparing peptide suppliers, research-grade peptides require verification of purity and identity — certificates of analysis should include HPLC purity verification. QI Supplements sources Chelohart from manufacturers operating under these standards. The extraction process ensures peptides are free from foreign DNA or protein substances, consistent with the Khavinson patented purification method.

The Heart Protocol: Chelohart, Ventfort, and Cardio 3

For most people who come to QI for cardiovascular health support, the question is not just which single peptide to take. It is how to build the right peptide protocol for their situation.

Here are the three most common options.

Protocol 1: The starter

One peptide. One 10-day course. Test before committing.

Start with Chelohart 20 capsules. This is the lowest-cost entry point for heart tissue support. See how your body responds before adding Ventfort or moving to the full 30-day course. Many people notice improved energy production and overall vitality within the first course.

Protocol 2: The complete cardiovascular stack

Two peptides. Run both together for 30 days.

Chelohart for cardiac tissue. Ventfort for vessel tissue. This is the core protocol from Khavinson's published cardiovascular research. The synergistic effects of running both together address cardiovascular health through multiple aspects of the system simultaneously.

Chelohart 60 capsules — 30-day course
Ventfort 60 capsules — 30-day course

Take both with meals. 1 to 2 capsules of each, 1 to 2 times per day.

Protocol 3: The all-in-one

One capsule. Three specific peptides. Simpler routine.

Cardio 3 Plus combines Chelohart, Ventfort, and Vladonix in a single capsule. Same cardiovascular protocol. One bottle. This is the right pick for people who want broad cardiovascular health support without managing three products separately.

2 capsules daily with meals for 30 days. Repeat 2 to 4 times per year for optimal results.

Stacking Chelohart with Other Bioregulators

Chelohart fits naturally into broader Khavinson protocols. The heart depends on multiple systems working well. Supporting those systems helps heart function too.

With Cerluten (brain and nervous system): The nervous system controls heart rate and rhythm. The respiratory system connects to cardiac function through oxygen delivery. Cerluten supports the nervous system tissue that sends signals to the heart. Many people use Chelohart and Cerluten together in cardiovascular and cognitive aging protocols.

With Vesugen (vessel peptide,): Vesugen is the fast-acting vessel peptide. For people who want a quick vessel reset alongside the more gradual cardiac tissue support of Chelohart, starting with Vesugen then moving to Chelohart plus Ventfort is a common sequencing pattern. The synergistic effects of Vesugen and Chelohart address both circulatory efficiency and heart muscle function.

With Endoluten (pineal): The pineal gland controls circadian rhythm and melatonin. Sleep quality affects cardiac function and cellular repair. Many older adults who use Chelohart include Endoluten in the protocol for this reason. It was also one of the two main bioregulators in the 266-patient longevity trial cited above.

With Vladonix (thymus and immune): The immune system plays a role in heart tissue inflammation and cellular repair. Vladonix supports thymus function and immune system balance. It is included in the Cardiovascular System Peptide Bundle alongside Chelohart and Ventfort because immune system support has synergistic effects on cardiovascular health.

Chelohart is also compatible with support for the digestive system and other organ-specific protocols. Unlike many supplements, there are no known adverse interactions between Chelohart and other Khavinson bioregulators. You can combine up to five peptide complexes at the same time.

Who Chelohart Is For

This dietary supplement is for adults who want to support the long-term health of their heart at the cellular level. It fits if you are:

Over 40 and thinking ahead about age related cardiac decline
Already running a Khavinson protocol with Ventfort and want to add cardiac tissue support
Looking for a natural peptide approach to cardiovascular health rather than synthetic cardiac peptides
Building a peptide protocol based on Khavinson's clinical studies and animal studies
Looking for potential benefits from a dietary supplement that works at the cellular level

It is not a substitute for conventional treatments. It is not for people with chronic conditions including acute heart failure without guidance from a healthcare professional. If you have a diagnosed medical condition affecting the heart, talk to your healthcare provider before starting any peptide regimen.

Who should not take Chelohart

Do not take Chelohart if you have a known intolerance to the ingredients. Do not take it during pregnancy or while breastfeeding. If you take other medications for a heart or cardiovascular medical condition, consult your healthcare professional first. This product is not for people under 18.

Frequently Asked Questions

What is Chelohart made from?

Chelohart contains peptide complex A-14, extracted from the cardiac muscle of young animals — typically calves under 10 months. Each capsule contains 10mg of active natural cardiac muscle peptides. Other ingredients include microcrystalline cellulose, beet sugar, lactose, starch, and an emulsifier.

How is Chelohart different from Ventfort?

Ventfort targets blood vessel tissue. Chelohart targets cardiac tissue — the myocardial cells that make the heart beat. They cover different parts of the cardiovascular system. Both matter for cardiovascular health. They work best together for optimal results.

How long until I notice something?

Khavinson bioregulators work gradually. Do not expect a quick change. The effects build over a 10 or 30-day course and continue for months after you stop. Most people assess potential benefits after a full 30-day cycle. Stronger effects tend to come after two courses in a year.

Can I take Chelohart at the same time as Ventfort?

Yes. This is the standard protocol. Take each with meals. There are no known adverse interactions between Chelohart and Ventfort. The synergistic effects of combining both address multiple aspects of cardiovascular health simultaneously.

Does Chelohart require subcutaneous injection?

No. Chelohart is an oral capsule. You do not need subcutaneous injection or sterile technique. It is a natural peptide complex in capsule form, designed for daily oral use. This is one of the ways Chelohart differs from research peptides sold by some peptide suppliers for research purposes only.

What is Cardio 3 and how does it relate to Chelohart?

Cardio 3 combines Chelohart, Ventfort, and Vladonix in one capsule. If you want the full cardiovascular protocol in one product rather than three bottles, Cardio 3 is the simpler option. Same specific peptides, same dose, one capsule per day.

How often should I repeat a course?

Most people repeat 2 to 4 times per year. Peptide bioregulators have a long after-effect. The cardiac cells keep producing proteins for months after the course ends. You do not need to take it every day forever. This is a key difference from symptom management supplements that require daily dosing to maintain any effect.

Can I take Chelohart with other supplements?

Yes. Khavinson natural peptide bioregulators are compatible with other supplements and other medications in most cases. If you take prescription medication for a cardiovascular medical condition, consult your healthcare professional before starting. Always disclose all supplements to your healthcare provider.

Is Chelohart the same as Cardiogen?

No. Chelohart is a natural peptide complex (Cytomax) from cardiac tissue. Cardiogen is a synthetic single tetrapeptide (Cytogen). Chelohart acts more gradually and covers a wider range of heart tissue signals through multiple pathways. Cardiogen is faster and more targeted. They are different products for different use cases. Most people building a long-term peptide protocol for cardiovascular health start with Chelohart.

How does Chelohart differ from general cardiovascular supplements?

Most cardiovascular supplements work through symptom management or broad antioxidant support. They do not target cardiac tissue at the cellular level. What chelohart distinguishes is its tissue specificity. It contains specific peptides matched to cardiac cell metabolism. They interact with gene expression in myocardial cells directly, addressing the root cause of age related cardiac decline rather than masking symptoms.

The Bottom Line

The heart never gets a day off. Supporting it before something goes wrong matters more than most people realize. By the time something feels off, the age related declines in cellular function have usually been running for years.

Chelohart is Khavinson's targeted answer for cardiac tissue. It is not a cardiac drug. It is not a treatment. It is a dietary supplement built on 40 years of research and clinical studies into how short chain peptides can restore the cellular activity that keeps specific tissues functioning well as you age.

If you are building a cardiovascular health protocol, Chelohart and Ventfort together form the core. Cardio 3 puts them in one capsule for those who want simplicity. Either way, cardiac function and circulatory efficiency are different things. Both matter for overall vitality.

Start your heart health protocol
→ Chelohart 20 capsules — 10-day starter course
→ Chelohart 60 capsules — 30-day course
→ Cardio 3 Plus — Chelohart, Ventfort, and Vladonix combined
→ Cardiovascular System Peptide Bundle

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. The information in this article is for educational purposes only and is not medical advice. Talk to your doctor before starting any new supplement, especially if you have a medical condition or take prescription medication.

References

Khavinson VK, Morozov VG. Peptides of pineal gland and thymus prolong human life. Neuro Endocrinol Lett. 2003;24(3-4):233-240. PubMed: PMID 14523363

Khavinson VKh. Peptides and Ageing. Neuro Endocrinol Lett. 2002;23 Suppl 3:11-144. PubMed: PMID 12374906

Khavinson VK, Linkova NS, Kvetnoy IM, et al. Epigenetic mechanisms of peptide regulation of gene expression. Biochemistry (Moscow). 2015;80(3). DOI: 10.1134/S0006297915030062